Moleac.com
  • Home
  • About Us
    • Vision, Values & Mission
    • Milestones
    • Leadership
      • Management Team & Advisors
      • Board of Directors
      • Scientific Advisors & Collaborators
    • Our People, Our Company
    • Responsibility
  • R & D
    • Pipeline
    • Our Strategic Approach
    • Research & Development
    • Publications
  • Products
    • NeuroAiD™II
  • Partners
    • Our Commercial Partners
    • Commercial Partnering Opportunities
    • Research Opportunities
  • News
  • Library
  • Contact Us
  • Career
Select Page

Moleac at AD/PD 2025: Advancing Alzheimer’s Disease Management

Apr 3, 2025 | News

Our team is at the AD/PD International Conference in Vienna!

Come visit us at booth #80 to learn how we are making a difference in Alzheimer’s disease management.

We look forward to meeting you!

For more information about Moleac, visit www.moleac.com

Categories

  • Alzheimer News
  • News
  • Stroke News
  • TBI News

Recent Posts

  • Balancing Risk: New Systematic Review Explores VTE Prophylaxis in Intracranial Hemorrhage Patients
  • Moleac at the Forefront of Stroke Recovery at the 10ᵗʰ Ho Chi Minh Stroke Conference
  • Moleac Joins MCGM 2025 to Support Advancements in Geriatric and Alzheimer’s Care
  • 𝗔𝗦𝗡𝗔 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 | 𝗕𝗮𝗹𝗶, 𝗜𝗻𝗱𝗼𝗻𝗲𝘀𝗶𝗮 | 𝟴 – 𝟭𝟬 𝗔𝘂𝗴𝘂𝘀𝘁 𝟮𝟬𝟮𝟱
  • Meta-Analysis on NeuroAiD’s Role in Stroke Recovery to Be Featured at ASNA 2025
Previous News

New Study Reveals Long-Term Healthcare Impact of Pediatric TBI

←
Next News

Bringing Hope to Young Fighters: Moleac Partners with Kythe Foundation

→

Quick links

Home
About Us
Contact
Privacy Policy
Terms & Conditions

Find us

Moleac Pte Ltd

Contact

  • Helios #09-08, 11 Biopolis Way, Singapore 138667
  • +65 62113710
  • [email protected]

Connect

  • Follow
  • Follow
  • Follow
  • Follow

Copyright © 2003-2025. All Rights Reserved. NeuroAiD by Moleac Pte Ltd, Helios #09-08, 11 Biopolis Way, Singapore 138667

loading

Please wait while you are redirected to the right page...